Spyre Therapeutics, Inc. (SYRE)
NASDAQ: SYRE · IEX Real-Time Price · USD
25.49
-0.27 (-1.05%)
Jul 5, 2024, 4:00 PM EDT - Market closed
Spyre Therapeutics Analyst Ratings
Total Analysts
6
Consensus Rating
Strong Buy
Price Target
$43.00
Upside
+68.69%
Ratings History
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Wells Fargo | Wells Fargo | Buy Maintains $35 → $40 | Buy | Maintains | $35 → $40 | +56.92% | May 13, 2024 |
BTIG | BTIG | Strong Buy Maintains $32 → $40 | Strong Buy | Maintains | $32 → $40 | +56.92% | May 10, 2024 |
Baird | Baird | Buy Initiates $50 | Buy | Initiates | $50 | +96.16% | May 2, 2024 |
Stifel | Stifel | Strong Buy Reiterates $36 → $54 | Strong Buy | Reiterates | $36 → $54 | +111.85% | Mar 26, 2024 |
Wells Fargo | Wells Fargo | Hold → Buy Upgrades $12 → $35 | Hold → Buy | Upgrades | $12 → $35 | +37.31% | Mar 1, 2024 |
BTIG | BTIG | Strong Buy Initiates $32 | Strong Buy | Initiates | $32 | +25.54% | Dec 20, 2023 |
Stifel | Stifel | Strong Buy Maintains $23 → $27 | Strong Buy | Maintains | $23 → $27 | +5.92% | Dec 18, 2023 |
Jefferies | Jefferies | Strong Buy Initiates $31 | Strong Buy | Initiates | $31 | +21.62% | Dec 11, 2023 |
TD Cowen | TD Cowen | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Nov 29, 2023 |